The jointly organized by China Pharmaceutical Business Association and Sinopharm Global Procurement and Supply Chain Service Center was held in Shanghai recently. Mr. Kevin Gu, Senior Vice President, Head of Market Access, Commercial Diversity & International Business of Hasten Biopharmaceutical Co., Ltd. was invited to attend the conference and delivered a speech on "Exploring Supply Chain Integration Development for Innovative Pharmaceutical Enterprises".

Shanghai, May 4th , 2023 – Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has acquired the commercial rights in China for Rocephin®, a long-acting, broad spectrum cephalosporin antibiotic, from Swiss multinational healthcare company, Roche.

20 April, 2023 – CBC Group (“CBC”), Asia’s largest healthcare-dedicated investment firm headquartered in Singapore, and Hasten Biopharmaceutic Company Limited (“Hasten”), today jointly announced the completion of a US$315 million fundraising round for Hasten. Hasten is an innovation-driven pharmaceutical company backed by CBC, Hefei Industry Investment Group, and Feidong County of Hefei City.

The year of 2022 marked the 70th anniversary of the Patriotic Health Movement (Be shorted as ‘the movement’). On December 27, the 2022 National Patriotic Health Campaign Conference, with the theme of "70 years’ Patriotic Health Movement, Healthy China Tour - advocating a civilized, healthy, sustainable and environmental lifestyle, and helping to normalize epidemic prevention and control", was successfully held in Beijing.

Shanghai, December 16, 2022 - Aon Group, a global leading professional services firm, recently released its list of 2022 Best ESG Employers in China. Hasten Biopharma was awarded the " 2022 Aon China Best ESG Employer Agile Organization Award" for its efforts on sustainable organization building and innovation achievements.

On the morning of Nov. 23, the groundbreaking ceremony for Hasten Biopharma Hefei Production Base project (Yi Bo Sen Pharmaceutical Co., Ltd.) was held in Feidong, Hefei. Yuan Fei, member of the Standing Committee of Hefei Municipal Committee, attended the ceremony and announced the full start of the project. Summer Xia, CEO of Hasten Biopharma, Jiang Xin, General Manager of Hefei Industry Investment Group and Chairman & General Manager of Hefei Industry Investment Capital, Yao Fei, Secretary of Feidong County, Zhang Hong, CEO of RMB Business Group of CBC Group, Annie Lee, Chairman of the Board of Directors of Hasten Biopharma and Managing Director of CBC Group, Zhang Bo, Managing Director of CBC Broup and Director of Hasten Biopharma were present. Vice Governor of Feidong County, Ma Juanshu, hosted the ceremony. Representatives from related institutions of Feidong County and Hefei City participate in the start-up activities.